2023
Prostate cancer risk stratification using magnetic resonance imaging–ultrasound fusion vs systematic prostate biopsy
Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg M, Sprenkle P, Leapman M. Prostate cancer risk stratification using magnetic resonance imaging–ultrasound fusion vs systematic prostate biopsy. JNCI Cancer Spectrum 2023, 7: pkad099. PMID: 38085220, PMCID: PMC10733209, DOI: 10.1093/jncics/pkad099.Peer-Reviewed Original ResearchConceptsMagnetic resonance imaging-ultrasound fusionMRF-TBLow-risk diseaseSystematic biopsyLower riskRisk groupingProstate biopsyActive surveillanceHigh riskProstate cancer risk stratificationIntermediate-risk criteriaIntermediate-risk diseaseSystematic prostate biopsyCancer risk stratificationPrimary study objectiveNCCN guidelinesImage-guided approachLocalized cancerRisk stratificationBenign findingsProstate cancerClinical riskDiagnostic yieldRetrospective analysisBiopsy
2022
“En-Bloc” Enucleation With Early Apical Release Compared to Standard Holmium Laser Enucleation of the Prostate: A Retrospective Pilot Study During the Initial Learning Curve of a Single Surgeon
Press B, Ghiraldi E, Kim DD, Nair H, Johnson K, Kellner D. “En-Bloc” Enucleation With Early Apical Release Compared to Standard Holmium Laser Enucleation of the Prostate: A Retrospective Pilot Study During the Initial Learning Curve of a Single Surgeon. Urology 2022, 165: 275-279. PMID: 35063465, DOI: 10.1016/j.urology.2022.01.011.Peer-Reviewed Original ResearchConceptsEn-bloc approachInitial learning curveHolmium laser enucleationSingle surgeonLaser enucleationApical releaseLearning curvePost-operative complicationsRetrospective pilot studyLength of stayEn bloc techniqueEn-bloc enucleationOperative efficiencyMann-Whitney UPatient demographicsMajor complicationsOperative timeConsecutive menFunctional outcome
2021
Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI
Press BH, Khajir G, Ghabili K, Leung C, Fan RE, Wang NN, Leapman MS, Sonn GA, Sprenkle PC. Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI. Urology 2021, 155: 96-100. PMID: 34087311, DOI: 10.1016/j.urology.2021.05.035.Peer-Reviewed Original ResearchConceptsPSA densityActive surveillanceConfirmatory biopsyPathologic upgradeNegative MRIProstate volumeProstate cancerFavorable intermediate-risk prostate cancerNegative baselineIntermediate-risk prostate cancerLow-grade prostate cancerLower prostate volumeMedian PSA densityNormal baseline MRIUpgraded Gleason scoreCohort of patientsSubset of patientsLarge academic centerPI-RADS 2Intensity of surveillanceAbility of PSABiopsy upgradeGG1 cancerGleason upgradeMedian PSA
2018
The ultrasound characteristics of regions identified as suspicious by magnetic resonance imaging (MRI) predict the likelihood of clinically significant cancer on MRI–ultrasound fusion‐targeted biopsy
Press B, Rosenkrantz AB, Huang R, Taneja SS. The ultrasound characteristics of regions identified as suspicious by magnetic resonance imaging (MRI) predict the likelihood of clinically significant cancer on MRI–ultrasound fusion‐targeted biopsy. BJU International 2018, 123: 439-446. PMID: 30415476, DOI: 10.1111/bju.14615.Peer-Reviewed Original ResearchConceptsCancer detection rateMagnetic resonance imagingGleason scoreHypoechoic regionsInstitutional review board-approved databaseResonance imagingProstate-specific antigen densityFusion-targeted biopsyMultivariable regression analysisDetection rateProstate cancer detectionSignificant PCaUltrasonography findingsSingle surgeonSystematic biopsyProstate biopsySignificant cancerUnivariate analysisAntigen densityMRI suspicionSingle radiologistHigh riskUltrasound characteristicsRegion of interestBiopsy